Penny Stocks To Watch Right Now; But Are They Buy or Sell?
If you are new to trading stocks, you may be unaware of what penny stocks are. According to the SEC, a penny stock is any equity that is trading below $5. This is important to know because if you have a smaller portfolio size, trading penny stocks may be the way to go. These equities can bring large amounts of profits in a small span of time compared to blue-chip stocks.
However, If you are new to the world of penny stocks you must be aware that a bad penny stock can result in heavy losses. Before trading them, you should do lots of market and company research. You might also want to practice with paper trading them first.
Paper trading penny stocks helps you develop your trading strategies, so you are better prepared when you invest real money. It will also help you put a plan together to find some of the top penny stocks to watch. If this is something that might interest you, check out this list of penny stocks to watch.
Penny Stocks Up Big In 2019
Just because penny stocks have a reputation for quick gains, doesn’t mean they can’t produce long-term bull trends. Though it isn’t an every-day occurrence, there are certain penny stocks to watch that have breakthrough years and quarters.
Some of these companies can go on to produce sustained moves over the course of months and even years. There are a few herein that have done just that (so far in 2019). The biggest focus for these is on whether or not these moves can sustain themselves into the end of the year or beyond.
Penny Stocks To Buy Or Sell #4: Jaguar Health Inc. (JAGX)
The next company on this list also hails from the biotechnology sector. Jaguar Health Inc. (JAGX Stock Report) is focused on developing novel gastrointestinal treatments from plants found in rainforest areas. The company’s primary product is called Mytesi. This is the only FDA-approved diarrhea treatment that has been studied specifically in adults with HIV/AIDS.
Jaguar Health had some positive price action through the first 2 days of this week. First off, the stock price rose by nearly 9% during November 11th’s trading session. This momentum is not slowing down as the biotech penny stock continued higher on November 12th.
With new highs this week of $1.22, JAGX stock has jumped over 60% so far. In addition, the company also announced that it will be hosting an investor call on November 14th regarding the analysis of its HALT-D study of Mytesi. Will this be a catalyst for additional speculative trading this week?
Penny Stocks To Buy Or Sell #3: Bionano Genomics Inc. (BNGO)
Up next is a very interesting company that is taking a different approach to improving the world of medicine. Bionano Genomics Inc. (BNGO Stock Report) is a genome analysis company developing its Saphyr system. Genome analysis is where you dive into the DNA sequence and attempt to identify any potential problems. The company’s system is ultra-specific and is designed to accelerate the discovery of new therapeutic targets.
[Read More On BNGO] 4 Penny Stocks To Buy For Under $1 Right Now
Recently, Bionano has released a few press releases that brought investors to this penny stock. BNGO stock is no stranger to big breakouts either. A few weeks back, we saw shares of this penny stock jump to highs of $4.70. On November 7th, the company reported its Q3 financial results and provided investors with a business update.
In addition, Bionano’s Saphyr System had its results presented from multiple studies. It showed that the system is able to be utilized for a variety of disease indications. At the annual meeting of the Association for Molecular Pathology, the company reported results from studies.
“We are pleased to see our users succeed in addressing their needs using Saphyr and with the progress clinicians are making towards establishing Saphyr as the leading platform for streamlining cytogenetic testing,” commented Erik Holmlin, Ph.D., CEO of Bionano.
Penny Stocks To Buy Or Sell #2: Acasti Pharma Inc. (ACST)
Kicking things off is Acasti Pharma Inc. (ACST Stock Report). This is a biopharmaceutical company that creates and sells prescription drugs using omega-3 fatty acids derived from krill oil. This is Acasti’s focus because it believes that the market is in need of a safe omega-3 therapeutic option. The company’s lead product candidate is CaPre and it aims to treat severe hypertriglyceridemia.
This penny stock is looking promising thus far on November 12th. During premarket trading hours, Acasti’s stock price rose from $1.83 to $2.02, a 10% gain. On November 13th, the company is expected to have its Q2 fiscal conference call which could be a reason for this strong move.
Furthermore, the company recently announced that it has a publication for its CaPre Pharmacokinetics study in a peer-reviewed journal. Thanks to progress like this, its no wonder that ACST stock has managed to breakout by 163% year to date from January 2nd’s opening price of $0.82
Penny Stocks To Buy Or Sell #1: DGSE Companies Inc. (DGSE)
The company bringing this article to a close is DGSE Companies Inc. (DGSE Stock Report). It has a very diverse business model including retail stores, ecommerce, and commercial services. In terms of its stores and ecommerce, DGSE buys and sells jewelry and bullion product. In addition, its commercial services are designed to help businesses reduce waste and protect their intellectual property.
DGSE Companies recently announced its Q3 financial results and it has immediately had an impact on the company’s stock. The financials showed that the company increased its total revenue by 60% and its gross income by over 50%. While these numbers are great, the most important number is the profits which were over $1 million. These strong numbers have led to an early 11% gap up for the penny stock.
But this isn’t just a story for November. DGSE stock has impressed investors most of this year. It’s one of the biggest overall movers of the bunch. On January 2, shares traded around $0.45 and with new 52-week highs this week, this penny stock has solidified a move of over 270% year to date. Can this continue into the end of 2019?